About UMEDICA
UMEDICA is a Healthcare company based in Mumbai (India) founded in 1982. Pharmaceutical formulations manufacturing and exporting from India. The company has 869 employees. Its Indian entity Umedica Laboratories Private Limited reported revenue of ₹994 Cr. UMEDICA offers products and services including Injections and Tablets. Its focus areas include Pharmaceuticals, Manufacturing, Formulations and Drug Production.
Company details
UMEDICA Laboratories Pvt. Ltd. was established in 1982 and is recognized as a leading manufacturer of pharmaceutical formulations in India. A government-recognized export house, it serves over 85 countries with products like injections, tablets, and capsules that adhere to international quality standards. Facilities are equipped with advanced technology and have received certifications such as WHO-GMP and US FDA. Over 1000 qualified professionals are employed, and research is conducted at a dedicated center approved by the Indian government. Operations are supported by strict quality controls and innovative development efforts.
- Headquarters Mumbai, India
- Employees 869
- SectorsHealthcare
- Email••••••••
- Social LinkedIn X Facebook
- Legal Name Umedica Laboratories Pvt. Ltd
- Date of Incorporation 05 Jan, 1982
- Jurisdiction Pardi, Gujarat, India
- Annual Revenue₹994 Cr
FY 2025 · +21% YoY
- Net Profit₹58.26 Cr
FY 2025 · 6% margin
- EBITDA₹157 Cr
FY 2025 · 16% margin
- Employee Count869
Associated legal entities of UMEDICA
UMEDICA operates through Umedica Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Umedica Laboratories Private Limited CIN U24231GJ1982PTC141202 | Active | 05 Jan 1982 | Pardi, Gujarat | ₹994 Cr | 869 | 4 | View details |
Products & Services of UMEDICA
UMEDICA offers a comprehensive portfolio of products and services, including Injections and Tablets.
Injections are produced by UMEDICA for chronic and acute therapies, ensuring compliance with global quality standards.
Tablets are manufactured by UMEDICA using advanced facilities, covering a range of therapeutic needs.
Board of directors of Umedica Laboratories Private Limited (UMEDICA)
Umedica Laboratories Private Limited is the primary company behind UMEDICA. The board of Umedica Laboratories Private Limited currently have 3 directors; the longest-serving is Manish Umed Doshi, appointed in 1982. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manish Umed Doshi DIN 00210389 | Managing Director | 05 Jan 1982 | 44 yrs 9 mo | Umedica Laboratories Private Limited |
| Vandana Manish Doshi DIN 00211618 | Director | 17 Mar 2017 | 9 yrs 7 mo | Umedica Laboratories Private Limited |
| Rupesh Suryakant Kamdar DIN 02358348 | Director | 02 Aug 2018 | 8 yrs 2 mo | Umedica Laboratories Private Limited |
People of UMEDICA
17 people are tracked at UMEDICA (6 in leadership, 11 in team); the tracked headcount is 869.
| Name | Role | Group |
|---|---|---|
Anil Kashyap | Head Engineering Department | Leadership |
Hidaytulla Aga | Vice President - Head R&d (formulation Development) | Leadership |
Latish Salian | Senior General Manager | Leadership |
Prajakt Gupte | Assistant General Manager | Leadership |
Swapnil Masal | Deputy General Manager | Leadership |
Abhishek Jain | Assistant General Manager | Leadership |
Nikhil Joshi | Assistant Manager | Team |
Kavindra Thakre | AGM Quality Assurance | Team |
Dharmendra Jain | Sr. Manager (lead Quality Assurance Function) | Team |
Vivek Pandey | Senior Executive In Oral Manufacturing | Team |
Abhishek Singh | Quality Control Officer | Team |
Amoli Doshi | Management | Team |
| Executive | Team | |
Vishal Bhosale | Senior Executive | Team |
Ajay Khedkar | Regulatory Affairs Manager | Team |
Kanchan Sonawane | Assistant Manager - HR | Team |
Kamlesh Suryawanshi | Senior Officer (expert In Track And Trace, Qualification,qms, Risk Assessment, Conectivity With 5pl) | Team |
Complete people profiles for UMEDICA
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of UMEDICA
Figures of Umedica Laboratories Private Limited, the primary company behind UMEDICA, for FY 2025. Revenue was ₹994 Cr (+21% year on year). Net profit was ₹58.26 Cr (6% margin). EBITDA was ₹157 Cr (16% margin). Revenue has grown at a compounded annual rate of +77% over three years and +56% over five years.
- ₹994 CrRevenue · FY 2025 · +21% YoY
- ₹58.26 CrNet profit · 6% margin
- ₹157 CrEBITDA · 16% margin
- ₹3.60 CrPaid-up capital
- 869Employees (provident fund records)
- +77%Revenue CAGR, 3 years
- +56%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Umedica Laboratories Private Limited are on its company page.
Detailed financial statements for UMEDICA
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Umedica
Complete news archive for UMEDICA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UMEDICA
UMEDICA was founded in 1982.
UMEDICA is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
UMEDICA has 869 employees.
The primary company behind UMEDICA, Umedica Laboratories Private Limited, reported revenue of ₹994 Cr for FY 2025, up 21% year on year.
UMEDICA Laboratories Pvt. Ltd. was established in 1982 and is recognized as a leading manufacturer of pharmaceutical formulations in India. A government-recognized export house, it serves over 85 countries with products like injections, tablets, and capsules that adhere to international quality standards. Facilities are equipped with advanced technology and have received certifications such as WHO-GMP and US FDA. Over 1000 qualified professionals are employed, and research is conducted at a dedicated center approved by the Indian government. Operations are supported by strict quality controls and innovative development efforts.
UMEDICA offers Injections and Tablets.
UMEDICA operates through Umedica Laboratories Private Limited.
The legal entities of UMEDICA currently have 4 directors, including Manish Umed Doshi, Rupesh Suryakant Kamdar, Vandana Manish Doshi and others.